DIACOMIT® is an anti-epileptic drug containing stiripentol as the active substance. DIACOMIT® is to be used as an add-on therapy to Clobazam and Valproate (other anti-epileptic drugs) for Dravet syndrome patients to treat generalised tonic-clonic seizures when these are not adequately controlled with Clobazam and Valproate. The Dravet syndrome is a rare form of epilepsy since the … Continue reading About DIACOMIT®